Drawing for Serial No. 79336458

USPTO serial 79336458

Serial No. 79336458

Reviewed by CopyMark Law Group

Reg. 7095448Status 700Registered
Filing date
Status date
Registration date
Jul 4, 2023
Examiner
JARAMILLO, JAVIER R
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79336458?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles Ho

Charles Ho BYIP LTD.5465 Legacy Drive, Suite 650Plano, TX 75024UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Immunostimulants; nutraceutical preparations for therapeutic and medical purposes for use as a dietary supplement; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of autoimmune diseases, cancer and tumor; stem cells for medical purposes; biological tissue cultures for medical purposes; diagnostic preparations for medical purposes; stem cells for veterinary purposes; biological tissue cultures for veterinary purposes; diagnostic preparations for veterinary purposes; blood products for medical purposes, namely, blood plasma and blood for medical purposesACTIVE—
042Technological research in the field of genome editing, pharmaceuticals, clinical medicine and biochemistry; conducting technical project studies, namely, conducting technical research in the field of medical and pharmaceutical studies; research and development of new products for others; scientific laboratory services; scientific research; quality inspection in the nature of product quality evaluation; product quality evaluation; quality system certification services, namely, providing quality assurance services in the field of genome editing and pharmaceuticals to determine conformity with certification standards; quality control for others; biological research; scientific research in the nature of conducting clinical trials for othersACTIVE—
044Nursing, medical; pharmaceutical consulting; therapy services being medical services, namely, stem cell therapy services, somatic cell therapy services, cancer therapy services, genetic disease therapy services, inflammation therapy services and immunotherapy services; alternative medicine services; human tissue bank services; animal breeding; veterinary assistance in the nature of veterinary testing for diagnostic and treatment purposes; medical clinic services; hospital servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 19, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 31, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 5, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 5, 2023FIMPFINAL DISPOSITION PROCESSED—
Oct 4, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 4, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 4, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 25, 2023GPNXNOTIFICATION PROCESSED BY IB—
Apr 18, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 18, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 5, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 5, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 29, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 15, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 15, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Mar 15, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 15, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 15, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 13, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Mar 13, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 13, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 13, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 9, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 8, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 8, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 7, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 7, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 7, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 7, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 7, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 3, 2022RFNTREFUSAL PROCESSED BY IB—
Sep 15, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 15, 2022RFRRREFUSAL PROCESSED BY MPU—
Aug 20, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 19, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 14, 2022DOCKASSIGNED TO EXAMINER—
Mar 29, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 25, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 24, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance